JG
NKTR icon

Jain Global’s Nektar Therapeutics NKTR Stock Holding History

Jain Global’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.6M Buy
36,181
+18,882
+109% +$1.08M 0.01% 621
2025
Q4 		$731K Sell
17,299
-15,488
-47% -$867K ﹤0.01% 760
2025
Q3 		$1.87M Sell
32,787
-96,031
-75% -$3.18M 0.01% 552
2025
Q2 		$3.33M Buy
+128,818
New +$1.45M 0.03% 410

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jain Global's NKTR Position: Q1 2026 in Review

Jain Global increased its Nektar Therapeutics (NKTR) stake by 109% in Q1 2026, buying an estimated $1.08M and bringing the position to 36,181 shares worth $2.6M. The position accounts for 0.01% of the portfolio, ranked #621.

Jain Global first reported a position in NKTR in Q2 2025 and has held it in 4 quarters since. The position peaked at $3.33M in Q2 2025. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Jain Global held 36,181 shares of Nektar Therapeutics worth $2.6M as of Q1 2026.
  • Jain Global bought 18,882 Nektar Therapeutics shares in Q1 2026, an estimated $1.08M.
  • Nektar Therapeutics made up 0.01% of Jain Global's portfolio in Q1 2026, its #621 holding.
  • Jain Global first reported a position in Nektar Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Jain Global's Nektar Therapeutics position peaked at $3.33M in Q2 2025.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.